跳至主要内容
临床试验/NCT00999492
NCT00999492已完成4 期

Selection of Aspheric Diffractive Multifocal IOLS Based on Corneal Wavefront

Mark Packer, MD, FACS1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
8
试验地点
1
主要终点
Frequency of spectacle wear

研究概览

简要总结

Given the availability of aspheric diffractive IOLs with varying negative spherical aberration it may be feasible, by selecting the best fit IOL, to minimize aberrations and thereby maximize visual performance.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 years of age or older
  • •Scheduled to undergo bilateral cataract or refractive lens surgery
  • •Visual potential of 20/30 or better in each eye after lens removal and IOL implantation
  • •Naturally dilated pupil size (in dim light) > 3.5 mm (with no dilation medications) for both eyes
  • •Preoperative regular corneal astigmatism of 2.5 D or less
  • •Clear intraocular media other than cataract
  • •Availability, willingness, and sufficient cognitive awareness to comply with examination procedures

排除标准

  • •Ocular disease other than cataract which could potentially limit uncorrected visual acuity or visual performance.
  • •Astigmatism not correctable by limbal relaxing incisions (greater than 2.5 D)
  • •Use of systemic or ocular medications that may affect visual outcomes
  • •Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus, immunocompromised, etc.)
  • •Uncontrolled systemic or ocular disease
  • •History of ocular trauma or prior ocular surgery
  • •Amblyopia or strabismus
  • •Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
  • •Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal disorders) that are predicted to cause future acuity losses to a level of worse than 20/30
  • •Subjects who may be expected to require retinal laser treatment or other surgical intervention
  • •Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome)
  • •Pupil abnormalities (non-reactive, tonic pupils or abnormally shaped pupils)
  • •Contact lens usage within 6 months for PMMA lenses, 1 month for gas permeable lenses or 1 week for extended-wear and daily-wear soft lenses
  • •Requiring an intraocular lens power <15.0 or >26.0 diopters

结局指标

主要结局

Frequency of spectacle wear

时间窗: 3 months postoperatively

次要结局

  • Frequency and degree of visual symptoms(3 months postoperatively)

研究者

发起方
Mark Packer, MD, FACS
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mark Packer, MD, FACS

Sponsor-Investigator

Drs. Fine, Hoffman and Packer, LLC

研究点 (1)

Loading locations...

相似试验

Selection of Aspheric Diffractive Multifocal... | 临床试验